GSK

GSK | NYSE

Price Alert Chart Builder DCF Calculator

$49.65

-$0.06 (-0.12%)

At close: Sep 24, 2026, 4:00 PM ET

$49.65

$0 (0.00%)

After-hours: Sep 24, 2026, 5:46 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	5.59B	2.95B	6.13B	5.49B	3.52B	5.1B
Depreciation & Amortization	3.7B	2.55B	2.85B	2.64B	2.12B	2.05B
Stock-Based Compensation	n/a	344M	n/a	n/a	343M	337M
Other Working Capital	-608.37M	2.04B	288.39M	-1.19B	2.5B	2.72B
Other Non-Cash Items	-1.53B	-1.38B	1.05B	2.66B	584M	-1.24B
Deferred Income Tax	n/a	n/a	-1.08B	-965.72M	n/a	n/a
Change in Working Capital	-608.37M	2.09B	-1.06B	-1.67B	1.39B	2.19B
Operating Cash Flow	7.14B	6.55B	7.89B	8.16B	7.95B	8.44B
Capital Expenditures	-1.32B	-2.98B	-1.63B	-1.41B	-2.65B	-1.95B
Cash Acquisitions	-4.37B	1.37B	-1.72B	-3.79B	185M	2.85B
Purchase of Investments	-89.98M	n/a	-152.9M	-177.38M	n/a	-1M
Sales Maturities Of Investments	195.62M	21M	2.37B	294.4M	18M	3.27B
Other Investing Acitivies	1.46B	-1.22B	14.92M	-4.43B	-1.03B	-2.97B
Investing Cash Flow	-5.72B	-1.23B	-2.4B	-10.88B	-1.78B	2.16B
Debt Repayment	1.47B	-1.17B	-2.95B	-5.69B	-2B	-4.03B
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-2.51B	-2.44B	-2.79B	-4.27B	-4B	-3.98B
Other Financial Acitivies	-573.16M	-1.14B	-341.84M	11.98B	-1.61B	-2.15B
Financial Cash Flow	-1.59B	-4.73B	-6.07B	2.05B	-7.59B	-10.13B
Net Cash Flow	-206.06M	545M	-735.58M	-1.31B	-1.44B	431M
Free Cash Flow	5.82B	3.57B	6.26B	6.75B	5.3B	6.5B
Adj. Free Cash Flow	5.82B	3.23B	6.26B	6.75B	4.96B	6.16B
Maintenance CapEx	-775.14M	-2.53B	-1.2B	n/a	-2.5B	-1.95B
Growth CapEx	-543.32M	-450.28M	-437.78M	-1.41B	-151.89M	n/a
Owner Earnings	6.37B	4.02B	6.7B	8.16B	5.45B	6.5B